Search results
Results From The WOW.Com Content Network
Florida Amendment 3 [1] was a proposed constitutional amendment to the Florida Constitution subject to a direct voter referendum on November 5, 2024, that would have legalized cannabis for possession, purchase, and recreational use in Florida for adults 21 years or older. The amendment achieved a majority 56% support among voters in the U.S ...
A motorist drives near AYR Cannabis Dispensary in Panama City, Florida on Oct. 24, 2024. Marijuana ballot measure Amendment 3 will be voted upon on Nov. 5.
[59] [60] Pennsylvania HB 2210, legalization was introduced by sponsor Amen Brown and referred to Health Committee 2024-04-09; the matching senate bill SB 846 dates from 2023. [61] [62] The Florida Supreme Court issued a ruling on April 1 that the Florida marijuana legalization initiative, 2024 Florida Amendment 3, would appear on the November ...
This law also includes regulations for a user registry, caregiver possession, and treatment centers for purchasing consumable marijuana. Medical marijuana was adopted by Florida voters back in ...
Recreational marijuana is legal in 24 states — just under half the country — while 20 have partially legalized it for medicinal purposes. A few states, like Nebraska and North Carolina, still ...
The Florida Medical Marijuana Legalization Initiative, also known as Amendment 2, was on the November 8, 2016, ballot in Florida as an initiated constitutional amendment. The amendment was approved by 71.32% of the vote making it the highest percentage win in 2016 of any other state cannabis ballot in the United States.
Delaware, for instance, legalized adult recreational cannabis use in April 2023, but its first weed retailers are unlikely to open until 2026 unless a pending law allows medical dispensaries to ...
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]